Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCiusss de L'Est de l'Île de Montréal
About this trial
This study aims to evaluate esmolol's perfusion impact during induction and maintenance of general anesthesia, using Nociception-Level-guided control of nociception, in adult patients undergoing laparoscopic and lower abdominal surgery, on intraoperative remifentanil consumption and postoperative pain in the Post-Anesthesia Care Unit.
Eligibility criteria
Qualifiers
Fully consented, American Society of Anesthesiologists Classification Score 1-3 patients from 18yo to 65yo
Undergoing laparoscopic surgery associated with sub umbilical mini-laparotomy. Eligible surgeries will be hysterectomy (excluding vaginal approach) and left hemicolectomy, of duration time expected under 180 minutes, under general anesthesia
No allergy to one of the medications used in this study
Disqualifiers
Hypotension
Sinus bradycardia
Sick sinus syndrome
Second and third degree A-V block
Trial design
Treatments tested in this trial
- Esmolol Hydrochloride
- Saline
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov